Roche Holding AG (0TDF)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 59.11 |
|---|---|
| 52-week range | 39.63 – 59.37 |
| Return, 1 month / 3 months | +6.6% / +15.7% |
| Return, 1 year / 3 years | +36.7% / +82.5% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 27.3% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 0.49M USD |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Roche Holding AG is a healthcare company based in Basel, Switzerland. It works through two main divisions: pharmaceuticals, which develops and makes prescription medicines for cancer, immune disorders, infectious diseases and disorders of the nervous system, and diagnostics, which supplies tests, instruments and related products used in laboratories and hospitals. Its customers are mainly hospitals, clinics, laboratories and healthcare providers, and its medicines and diagnostic products are used in markets around the world.
The shares are listed on the London Exchange in UK under the code 0TDF, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Roche Holding AG (0TDF) trades on the London Exchange in UK. It last closed at USD 59.11 on 20 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 666 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.7% and over the last three months it rose 15.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.1% | ||
| From 52-week high | -0.4% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.7% | ||
| 6-month return | 14.8% | ||
| 12-month return, skipping the last month | 28.3% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.2% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.49M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +10.0% |
|---|---|
| 1 month | +6.6% |
| 3 months | +15.7% |
| 6 months | +14.8% |
| 1 year | +36.7% |
| 3 years | +82.5% |
| 5 years | +35.5% |
Signals
| 50-day / 200-day average | 54.95 / 53.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.07 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Mar 2026 | CHF 1.0007 |
| 28 Mar 2025 | CHF 0.8559 |
| 14 Mar 2024 | CHF 0.8752 |
| 16 Mar 2023 | CHF 0.8016 |
| 17 Mar 2022 | CHF 0.7765 |
| 18 Mar 2021 | CHF 0.7734 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.